Over the past several decades, great progress has been made on understanding mechanisms of gastric acid secretion for developing new anti-acid drugs.Until now most commonly used anti-acid drugs are histamine-2 receptor antagonists and proton pump inhibitors (PPIs) for patients to control acid related disease.However, several clinical limitations of these drugs had been reported.Recently, a new generation of potassium-competitive acid blockers (P-CABs) were launched for clinical use.It has been shown that these new drugs are more convenient and powerful to treat gastric acid-related diseases.In this article, we briefly reviewed the clinical use of this new anti-acid drug P-CAB.